Esperion Therapeutis.Inc. buy nadine86
Start price
11.05.23
/
50%
€1.37
Target price
11.06.23
-
Performance (%)
-6.13%
End price
12.06.23
€1.29
Summary
This prediction ended on 12.06.23 with a price of €1.29. With a performance of -6.13%, the BUY prediction for Esperion Therapeutis.Inc. by nadine86 closed slightly in the red. nadine86 has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Esperion Therapeutis.Inc. | -4.489% | -4.489% | 50.210% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by nadine86 for this prediction
In the thread Trading Esperion Therapeutis.Inc.
Die von nadine86 gewählte maximale Laufzeit wurde überschritten